Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 4701 - 4725 of 10517 in total
Experimental
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
LU-31130 is a rapid acting therapy developed by H. Lundbeck A/S to treat Psychosis, Schizophrenia and Schizoaffective Disorders. It acts at the Dopamine D4 receptors in the cortex and has low affinity for D2 receptors, adrenoceptors, muscarinic and histaminergic receptors. It provides anti-psychotic characteristic and a low incidence of extrapyramidal...
Investigational
Matched Description: … Lundbeck A/S to treat Psychosis, Schizophrenia and Schizoaffective Disorders. ... It provides anti-psychotic characteristic and a low incidence of extrapyramidal and cardiovascular side …
EVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being developed as a treatment for insomnia. It is being developed by Evotec Inc.
Investigational
Matched Description: … EVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being …
Flortaucipir is under investigation in clinical trial NCT03507257 (Longitudinal Early-onset Alzheimer's Disease Study Protocol).
Investigational
Matched Categories: … Diagnostic Uses of Chemicals …
Cositecan is the novel camptothecin derivative which is also known as Karenitecin. It has been developed for superior oral bioavailability and increased lactone stability. It is used to treat cancer.
Investigational
Experimental
Matched Mixtures name: … S GVD Phytoncide ... S GVD Phytoncide …
Caroxazone is an antidepressant that has been withdrawn from the market. It is a reversible monoamine oxidase inhibitor (MAOI) of both A and B monoamine oxidase subtypes. However, it presents a five-fold preference for the MAO-B subtype.
Withdrawn
Matched Description: … It is a reversible monoamine oxidase inhibitor (MAOI) of both A and B monoamine oxidase subtypes. …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Iopentol is used as a contrast medium.
Experimental
Matched Categories: … Diagnostic Uses of Chemicals …
Oxaprotiline is a norepinephrine reuptake inhibitor of the tetracyclic antidepressant family that is related to maprotiline. This drug was never marketed. Oxaprotiline is a racemic mixture of the isomers levoprotiline and dextroprotiline. Levoprotiline is the R or levo isomer of oxaprotiline (CGP-12,103-A). Dextroprotiline is the S or dextro isomer of...
Experimental
Matched Description: … Dextroprotiline is the S or dextro isomer of oxaprotiline (CGP-12,104-A). ... Levoprotiline is the R or levo isomer of oxaprotiline (CGP-12,103-A). ... Oxaprotiline is a racemic mixture of the isomers levoprotiline and dextroprotiline. …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Safrazine is a member of the hydrazine family with non-selective and irreversible inhibitor effects against monoamine oxidases. In 1960, it was used as an antidepressant but it is now discontinued.
Withdrawn
Matched Description: … Safrazine is a member of the hydrazine family with non-selective and irreversible inhibitor effects against …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Quercus acutissima whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Mixtures name: … S GVD Phytoncide ... S GVD Phytoncide …
Felcisetrag (TD-8954) has been used in trials studying the treatment of Enteral Feeding Intolerance and Gastrointestinal Motility Disorder.
Investigational
Matched Description: … Felcisetrag (TD-8954) has been used in trials studying the treatment of Enteral Feeding Intolerance and …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Experimental
Matched Iupac: … (S,1S)-N,4-dimethyl-N-(4-methylpent-3-en-1-yl)cyclohex-3-en-1-aminium …
Niguldipine is a calcium channel blocker drug (CCB) with a1-adrenergic antagonist properties.
Experimental
Experimental
Matched Categories: … Sex Hormones and Modulators of the Genital System …
Experimental
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Lithium was used during the 19th century to treat gout. Lithium salts such as lithium carbonate (Li2CO3), lithium citrate, and lithium orotate are mood stabilizers. They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they counteract both mania and depression. Lithium can also...
Experimental
Matched Description: … They are used in the treatment of bipolar disorder, since unlike most other mood altering drugs, they ... lithium ion Li+, which having a smaller diameter, can easily displace K+ and Na+ and even Ca+2, in spite of
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Carfentanil or carfentanyl (Wildnil) is an analogue of the popular synthetic opioid analgesic fentanyl, and is one of the most potent opioids known (also the most potent opioid used commercially). Carfentanil was first synthesized in 1974 by a team of chemists at Janssen Pharmaceutica which included Paul Janssen. It has...
Illicit
Investigational
Vet approved
Matched Description: … It has a quantitative potency approximately 10,000 times that of morphine and 100 times that of fentanyl ... , and is one of the most potent opioids known (also the most potent opioid used commercially). ... Carfentanil or carfentanyl (Wildnil) is an analogue of the popular synthetic opioid analgesic fentanyl …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Ravidasvir is under investigation in clinical trial NCT02961426 (Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection).
Investigational
Matched Description: … is under investigation in clinical trial NCT02961426 (Sofosbuvir Plus Ravidasvir for the Treatment of
Matched Categories: … Antivirals for treatment of HCV infections …
Investigational
Matched Categories: … Diagnostic Uses of Chemicals …
Dexchlorpheniramine is a potent S-enantiomer of chlorpheniramine. The salt form dexchlorpheniramine maleate as the active ingredient is available as a prescription drug indicated for adjunctive therapy for allergic and anaphylactic reactions. It is an antihistamine drug with anticholinergic (drying) and sedative actions. It disrupts histamine signaling by competing with histamine...
Experimental
Investigational
Matched Description: … Dexchlorpheniramine is a potent S-enantiomer of chlorpheniramine. …
Investigational
Matched Categories: … Mammalian target of rapamycin (mTOR) kinase inhibitors …
Experimental
Matched Categories: … Sex Hormones and Modulators of the Genital System …
Nadifloxacin has been used in trials studying the treatment of Acne Vulgaris.
Investigational
Matched Description: … Nadifloxacin has been used in trials studying the treatment of Acne Vulgaris. …
Matched Categories: … Antiinfectives for Treatment of Acne …
Displaying drugs 4701 - 4725 of 10517 in total